Thieme E-Books & E-Journals -
Back
Synfacts 2022; 18(09): 1032
DOI: 10.1055/s-0041-1738302
Innovative Drug Discovery and Development

Design and Synthesis of NTQ1062, a new Akt Inhibitor Clinical Candidate

Contributor(s):
Antonia F. Stepan (Roche)
,
Nadine Kuhl (Merck Sharp & Dohme)